EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 82 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $14,464 | -79.9% | 12,258 | +41.1% | 0.00% | – |
| Q1 2022 | $72,000 | +620.0% | 8,685 | +344.9% | 0.00% | – |
| Q4 2021 | $10,000 | -72.2% | 1,952 | -55.8% | 0.00% | – |
| Q3 2020 | $36,000 | +3500.0% | 4,419 | +2109.5% | 0.00% | – |
| Q1 2020 | $1,000 | -66.7% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | – | 200 | +2757.1% | 0.00% | – |
| Q2 2019 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 7 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 7 | -65.0% | 0.00% | – |
| Q4 2016 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 20 | -99.4% | 0.00% | -100.0% |
| Q1 2016 | $57,000 | – | 3,378 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| UBS OCONNOR LLC | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |